Le Lézard
Classified in: Health, Covid-19 virus
Subject: MRR

Fertility Services Market to grow by USD 5.27 Bn | North America to Emerge as Major Market | Technavio

NEW YORK, Jan. 10, 2022 /PRNewswire/ -- The "Fertility Services Market by Service and Geography ? Forecast and Analysis 2021-2025" report has been added to Technavio's offering. The elderly population is increasing steadily across the world. This has increased the incidence of infertility due to declining egg quality among women, which is making it difficult to conceive. In addition, the sedentary lifestyles of people in both developed and developing countries have increased the number of infertility cases. This is prompting individuals to opt for advanced treatment options, which is creating huge opportunities in the market.

Technavio estimates the fertility services market is to grow by USD 5.27 billion between 2020 and 2025, progressing at a CAGR of almost 6% during the forecast period.

Purchase our full report to know the exact growth variance and future growth opportunities in the market.
Download a Free Sample Before Purchasing

Market Dynamics

Factors such as rising prevalence of late parenthood, increase in fertility tourism, and the rising number of fertility clinics will drive the growth of the fertility services market during the forecast period. In addition, the rising cases of prostate cancer is expected to open multiple growth opportunities for players in the market. However, high complication rates and ethical, legal, and social issues in fertility services might hamper the market growth.

Company Profiles

Some of the companies covered in this report are Anecova SA, CRITEX GmbH, Esco Micro Pte. Ltd., Instituto Bernabeu SL, INVO Bioscience Inc, Merck KGaA, Monash IVF Group, The Cooper Companies Inc., Virtus Health Ltd., and Vitrolife AB, etc.

Competitive Analysis

The competitive scenario provided in the fertility services market report analyzes, evaluates, and positions companies based on various performance indicators. Some of the factors considered for this analysis include the financial performance of companies over the past few years, growth strategies, product innovations, new product launches, investments, growth in market share, etc.

Market Segmentation

Related Reports:

Female Infertility Drugs Market by Route of Administration and Geography - Forecast and Analysis 2021-2025

Ovulation Test Market by Type and Geography - Forecast and Analysis 2022-2026

Fertility Services Market Scope

Report Coverage


Page number


Base year


Forecast period


Growth momentum & CAGR

Accelerate at a CAGR of 6%

Market growth 2021-2025

USD 5.27 billion

Market structure


YoY growth (%)


Regional analysis

North America, Europe, APAC, MEA, and South America

Performing market contribution

North America at 33%

Key consumer countries

US, UK, China, Germany, and Italy

Competitive landscape

Leading companies, competitive strategies, consumer engagement scope

Companies profiled

Anecova SA, CRITEX GmbH, Esco Micro Pte. Ltd., Instituto Bernabeu SL, INVO Bioscience Inc, Merck KGaA, Monash IVF Group, The Cooper Companies Inc., Virtus Health Ltd., and Vitrolife AB

Market Dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and future consumer dynamics, market condition analysis for forecast period,

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

About Us

Technavio is a leading global technology research and advisory company. Their research and analysis focus on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions. With over 500 specialized analysts, Technavio's report library consists of more than 17,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio's comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.


Technavio Research
Jesse Maida
Media & Marketing Executive
US: +1 844 364 1100
UK: +44 203 893 3200
Email: [email protected]
Website: www.technavio.com/

SOURCE Technavio

These press releases may also interest you

at 12:05
Regulatory News: MaaT Pharma (EURONEXT: MAAT ? the "Company"), a French clinical-stage biotech and a pioneer in the development of Microbiome Ecosystem Therapies dedicated to improving survival outcomes for patients with cancer today announced that...

at 12:01
The "Global Genomics Market By Product & Service, By Application, By End User, By Technology, By Regional Outlook, Industry Analysis Report and Forecast, 2021-2027" report has been added to ResearchAndMarkets.com's offering. The Global Genomics...

at 12:00
Datavant, the leader in helping organizations securely connect health data today announced that the National COVID Cohort Collaborative Privacy-Preserving Record Linkage (N3C PPRL), powered by Datavant technology and Regenstrief Institute's Linkage...

at 12:00
As per Zion Market Research study, The Microcarrier Market was worth around USD 1,682.6 million in 2021 and is estimated to grow to about USD 3,046.4 million by 2028, with a compound annual growth rate (CAGR) of approximately 10.4 percent over the...

at 12:00
The Electrosurgery Market Size is expected to record a valuation of USD 9.39 Billion by 2028, Registering to Accelerate at a 5.10% CAGR, According to the most recent study by Brandessence Market Research & Consulting Pvt ltd. The Global...

at 12:00
Sysmex Inostics, a global leader in the liquid biopsy revolution, has expanded its offering of CLIA-validated tests to include AML-SEQtm, a focused panel to detect mutations of the three most prevalent genes found in Acute Myeloid Leukemia (AML) ?...

News published on 10 january 2022 at 02:30 and distributed by: